Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L30 pseudogene 1 (MRPL30P1) is a non-coding pseudogene present in the human genome, related by sequence homology to the protein-coding MRPL30 gene. Unlike its parent gene, which encodes a component of the mitochondrial large ribosomal subunit involved in mitochondrial protein synthesis, MRPL30P1 does not produce a functional protein and has no established biological function or role in disease. Pseudogenes such as MRPL30P1 are typically remnants of formerly functional genes that have lost the ability to encode proteins, although in rare cases some pseudogenes have regulatory functions through RNA-mediated mechanisms. There are no documented drugs, biomarker applications, or recognized therapeutic roles for MRPL30P1. As a result, it is not considered a therapeutic target.
None (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L30 pseudogene 1 (MRPL30P1).